JAMA/X
Aug 8, 2025, 13:05
HOPE Trial: Alteplase 4.5–24 Hours After Acute Ischemic Stroke
JAMA shared an insightful post on X:
“In patients with salvageable brain tissue identified by perfusion imaging who did not initially receive thrombectomy, alteplase given 4.5 to 24 hours after acute ischemic stroke onset may improve functional outcomes.”
Read the full article here.
Title: Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours
The HOPE Randomized Clinical Trial
Authors: Ying Zhou, Yaode He, Bruce C. V. Campbell, David S. Liebeskind, Changzheng Yuan, Hui Chen, Yanxing Zhang, Tingyu Yi, Zhongyu Luo, Zuowen Zhang, Changcai Meng, Jianhua Cheng, Hezhong Ouyang, Jin Hu, Fei Wang, Sheng Zhang, Qi Fang, Haitao Hu, Xuting Zhang, Yi Chen, Wansi Zhong, Maarten G. Lansberg, Shenqiang Yan, Min Lou
Stay informed with Hemostasis Today.
acute ischemic stroke
Alteplase
Bruce C. V. Campbell
Changcai Meng
Changzheng Yuan
David S. Liebeskind
Fei Wang
Haitao Hu
Health
Hematology
Hemostasis
Hemostasis Today
Hezhong Ouyang
Hui Chen
JAMA
Jianhua Cheng
Jin Hu
Maarten G Lansberg
Medicine
Min Lou
Qi Fang
Sheng Zhang
Shenqiang Yan
stroke
Thrombectomy
Tingyu Yi
Wansi Zhong
Xuting Zhang
Yanxing Zhang
Yaode He
Yi Chen
Ying Zhou
Zhongyu Luo
Zuowen Zhang
-
Aug 14, 2025, 23:47World Thrombosis Day: Know your Risk in DVT
-
Aug 14, 2025, 12:52JAMA Review: Immune Thrombotic Thrombocytopenic Purpura (iTTP)
-
Aug 14, 2025, 12:33Louise Bannon: The World Thrombosis Day Campaign is Calling on Industry Leaders
-
Aug 14, 2025, 10:58Thomas Reiser: Why October 13 Marks World Thrombosis Day?
-
Aug 14, 2025, 04:03Perioperative Thrombotic Risk Guide for Hematology Fellows
-
Aug 14, 2025, 23:47Health-related Quality of Life in Children with von Willebrand Disease
-
Aug 14, 2025, 17:54Omid Seidizadeh: From Genotype and Phenotype! Variability in Type 2 von Willebrand Disease
-
Aug 14, 2025, 17:36Samin Mohsenian: Thrombotic Paradox in Congenital Fibrinogen Deficiencies
-
Aug 14, 2025, 17:10Emmanuel J Favaloro: DOACs and Mechanical Coagulation Test Systems
-
Aug 14, 2025, 13:09Thrombin Generation Assay to Guide Factor Therapy With Fitusiran
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Jul 26, 2025, 17:56HIPEITHO Trial Achieves Remarkable Enrollment Milestone Across 72 Sites in the US and Europe
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Aug 14, 2025, 02:08Jordan Harry's Conversation on Cancer and Clot Risk with Thrombosis Canada
-
Aug 13, 2025, 15:50Will Parsons Honors National Leaders in Hematology: Drs. Fasipe, Powers and Tubman
-
Aug 13, 2025, 10:25Joshua Muia on His HTRS Leadership Role Impact
-
Aug 11, 2025, 05:16Andreas Calatzis: Any Information on Soviet Thrombelastographs?
-
Aug 9, 2025, 15:36NBCA: Blood Clot Survivor Runs 2025 NYC Marathon with Team Stop the Clot
Aug 14, 2025, 23:47
Aug 14, 2025, 23:47
Aug 14, 2025, 17:36
Aug 14, 2025, 17:10
Aug 14, 2025, 13:09
Aug 14, 2025, 12:52
Aug 14, 2025, 10:58
Aug 14, 2025, 04:03